Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

PFO Closure for Cryptogenic Stroke: Review of New Data and Results.

Rao S, Sila C.

Curr Treat Options Cardiovasc Med. 2013 Jun;15(3):360-71. doi: 10.1007/s11936-013-0243-8.

PMID:
23549665
2.

Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.

Paciaroni M, Agnelli G, Bertolini A, Pezzini A, Padovani A, Caso V, Venti M, Alberti A, Palmiero RA, Cerrato P, Silvestrelli G, Lanari A, Previdi P, Corea F, Balducci A, Ferri R, Falcinelli F, Filippucci E, Chiocchi P, Grandi FC, Ferigo L, Musolino R, Bersano A, Ghione I, Sacco S, Carolei A, Baldi A, Ageno W; FORI (Foramen Ovale Registro Italiano) Investigators.

Cerebrovasc Dis. 2011;31(2):109-16. doi: 10.1159/000321334. Epub 2010 Nov 17.

PMID:
21088390
3.

Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.

Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L; CLOSURE I Investigators.

JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.

4.

Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.

Li J, Liu J, Liu M, Zhang S, Hao Z, Zhang J, Zhang C.

Cochrane Database Syst Rev. 2015 Sep 8;(9):CD009938. doi: 10.1002/14651858.CD009938.pub2. Review.

PMID:
26346232
5.

PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis.

Ntaios G, Papavasileiou V, Makaritsis K, Michel P.

Int J Cardiol. 2013 Oct 30;169(2):101-5. doi: 10.1016/j.ijcard.2013.08.058. Epub 2013 Aug 28. Review.

PMID:
24041984
6.

Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.

Rengifo-Moreno P, Palacios IF, Junpaparp P, Witzke CF, Morris DL, Romero-Corral A.

Eur Heart J. 2013 Nov;34(43):3342-52. doi: 10.1093/eurheartj/eht285. Epub 2013 Jul 11. Review.

PMID:
23847132
7.

Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.

Pickett CA, Villines TC, Ferguson MA, Hulten EA.

Tex Heart Inst J. 2014 Aug 1;41(4):357-67. doi: 10.14503/THIJ-13-3879. eCollection 2014 Aug. Review.

8.

Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.

Taggart NW, Reeder GS, Lennon RJ, Slusser JP, Freund MA, Cabalka AK, Cetta F, Hagler DJ.

Catheter Cardiovasc Interv. 2017 Jan;89(1):124-133. doi: 10.1002/ccd.26518. Epub 2016 Mar 29.

PMID:
27027873
9.

Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.

Kwong JS, Lam YY, Yu CM.

Int J Cardiol. 2013 Oct 9;168(4):4132-8. doi: 10.1016/j.ijcard.2013.07.077. Epub 2013 Jul 24.

PMID:
23890879
11.

Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure.

Mirzada N, Ladenvall P, Hansson PO, Eriksson P, Dellborg M.

Int J Cardiol. 2015 Sep 15;195:293-9. doi: 10.1016/j.ijcard.2015.05.088. Epub 2015 May 21.

PMID:
26056962
12.

Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses.

Udell JA, Opotowsky AR, Khairy P, Silversides CK, Gladstone DJ, O'Gara PT, Landzberg MJ.

Can J Cardiol. 2014 Oct;30(10):1216-24. doi: 10.1016/j.cjca.2014.05.004. Epub 2014 May 9.

PMID:
25154803
13.

Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure.

Yoon JH, Kim JS, Lee DH, Shim EJ, Lee SY, Min KS, Cho DJ, Lee HR.

Korean Circ J. 2011 Jul;41(7):356-62. doi: 10.4070/kcj.2011.41.7.356. Epub 2011 Jul 30.

14.

Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.

Davies A, Ekmejian A, Collins N, Bhagwandeen R.

Heart Lung Circ. 2017 Mar;26(3):246-250. doi: 10.1016/j.hlc.2016.06.1211. Epub 2016 Aug 5.

PMID:
27555053
15.
16.

Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism.

Agarwal S, Bajaj NS, Kumbhani DJ, Tuzcu EM, Kapadia SR.

JACC Cardiovasc Interv. 2012 Jul;5(7):777-89. doi: 10.1016/j.jcin.2012.02.021.

17.

Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience.

Ford MA, Reeder GS, Lennon RJ, Brown RD, Petty GW, Cabalka AK, Cetta F, Hagler DJ.

JACC Cardiovasc Interv. 2009 May;2(5):404-11. doi: 10.1016/j.jcin.2008.12.015.

18.

Multidisciplinary assessment of PFO with substantial right-to-left shunting and medium-term follow-up after PFO device closure: A single-center experience.

He L, Cheng GS, Du YJ, Zhang YS.

J Interv Cardiol. 2017 Aug;30(4):362-367. doi: 10.1111/joic.12396. Epub 2017 Jun 1.

19.

Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.

Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA.

JACC Cardiovasc Interv. 2013 Dec;6(12):1316-23. doi: 10.1016/j.jcin.2013.08.001. Epub 2013 Oct 16. Review.

20.

PFO closuRE and CryptogenIc StrokE (PRECISE) registry: a multi-center, international registry.

Wöhrle J, Bertrand B, Søndergaard L, Turner M, Scholtz W, Ibrahim R, Bourlon F.

Clin Res Cardiol. 2012 Oct;101(10):787-93. Epub 2012 Apr 10.

PMID:
22487724

Supplemental Content

Support Center